Statistical Measurement [Domain]
Statistical Measurement [Domain]
Award Timing Predetermined
Award Timing Predetermined [Flag]
Related Party Transaction [Axis]
Related Party Transaction [Axis]
2026 (remaining 9 months)
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Entity File Number
Entity File Number
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Tabular List, Table
Tabular List [Table Text Block]
Leases [Abstract]
Leases [Abstract]
Percentage of royalty income shared
Percentage Of Royalty Income Shared
Percentage of royalty income shared.
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Accrued expenses and other current liabilities
Increase Decrease In Accrued Expenses And Other Current Liabilities
Accrued expenses and other current liabilities.
Accrued expenses and other current liabilities
Total accrued expenses and other current liabilities
Accrued Expenses And Other Current Liabilities
Accrued expenses and other current liabilities.
Accounts payable
Increase (Decrease) in Accounts Payable
One Customer
One Customer [Member]
One Customer
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Warrant issued to purchase common stock (in shares)
Number of warrants (in shares)
Class of Warrant or Right, Outstanding
Net loss per share, basic (in dollars per share)
Earnings Per Share, Basic
Adjustment to Compensation:
Adjustment to Compensation [Axis]
Related Parties
Related Party Transactions Disclosure [Text Block]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
License And Collaboration Agreements [Abstract]
License And Collaboration Agreements [Abstract]
License and collaboration agreements.
Schedule of Significant Revenue and Expense Categories
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Inventory Disclosure [Abstract]
Inventory Disclosure [Abstract]
Torii warrant expense
Adjustments to Additional Paid in Capital, Warrant Vested
Adjustments to Additional Paid in Capital, Warrant Vested
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Concentration risk percentage
Concentration Risk, Percentage
2029
Finance Lease, Liability, to be Paid, Year Three
Torii Amendment, Tranche One
Torii Amendment, Tranche One [Member]
Torii Amendment, Tranche One
Shares issuable upon exercise of stock options
Stock Options
Share-Based Payment Arrangement, Option [Member]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Total stockholders’ equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Stock-based compensation
Stock Based Compensation [Member]
Stock Based Compensation [Member]
License and collaboration revenue
License and collaboration revenue
License And Collaboration Revenue [Member]
License and collaboration revenue.
Insider Trading Policies and Procedures [Line Items]
Stock-based compensation
Total stock-based compensation
Share-Based Payment Arrangement, Expense
Common stock, shares authorized (in shares)
Common Stock, Shares Authorized
Shares issued (in shares)
Stock Issued During Period, Shares, New Issues
Current assets:
Assets, Current [Abstract]
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Total liabilities and stockholders’ equity
Liabilities and Equity
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities and Equity [Abstract]
Cover [Abstract]
Cover [Abstract]
Maximum
Maximum [Member]
Non-cash R&D expense related to Torii warrant vesting
Research And Development Expense, Noncash
Research And Development Expense, Noncash
General and administrative (including payroll)
General and Administrative Expense [Member]
Right-of-use asset obtained in exchange for lease obligation
Right Of Use Asset Obtained In Exchange For Lease Obligation
Right of use asset obtained in exchange for lease obligation.
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Maximum cost repayment period
Collaborative Arrangement, Rights And Obligations, Cost Repayment Period, Maximum
Collaborative Arrangement, Rights And Obligations, Cost Repayment Period, Maximum
Schedule of Maturities of Operating Leases
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Non-vested shares under restricted stock grants
Restricted Stock [Member]
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Treasury Stock
Treasury Stock, Common [Member]
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Pay vs Performance Disclosure [Line Items]
Maximum out of pocket costs paid by the other party
Collaborative Arrangement, Rights and Obligations, Amount Paid By Other Party, Maximum
Collaborative Arrangement, Rights and Obligations, Amount Paid By Other Party, Maximum
Class of Warrant or Right [Axis]
Class of Warrant or Right [Axis]
Lease liability
Operating Lease, Liability
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Torii Agreement, Phase 3 Program
Torii Agreement, Phase 3 Program [Member]
Torii Agreement, Phase 3 Program
Amortization of finance lease right-of-use asset
Amortization right-of-use assets
Finance Lease, Right-of-Use Asset, Amortization
Entity Shell Company
Entity Shell Company
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Company Selected Measure Amount
Company Selected Measure Amount
2029
Lessee, Operating Lease, Liability, to be Paid, Year Three
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Expired (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Name
Measure Name
Cost of license and collaboration revenue
Cost of license and collaboration revenue
Cost of License And Collaboration Revenue
Cost of collaboration revenue.
Schedule of Stock Based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Torii amendment
Warrants issued in connection with Torii amendment
Torii Amendment [Member]
Torii amendment.
Operating lease liability
Operating Lease, Liability, Current
Interest on lease liabilities
Finance Lease, Interest Expense
Document Fiscal Period Focus
Document Fiscal Period Focus
Award Timing Method
Award Timing Method [Text Block]
Award Type [Axis]
Award Type
Award Type [Axis]
Total assets
Assets
Gross to net reserves
Gross to Net Reserves
Gross to net reserves
Entity Trading Symbol
Trading Symbol
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Term of finance lease
Lessee, Finance Lease, Term of Contract
Entity Address, City or Town
Entity Address, City or Town
Change in deferred R&D services and R&D funding liability
Change In Deferred Costs, Research And Development and Research And Development Funding Liability, Net
Change In Deferred Costs, Research And Development and Research And Development Funding Liability, Net
Cash flows from operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Weighted average discount rate
Finance Lease, Weighted Average Discount Rate, Percent
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Inventory
Inventory Disclosure [Text Block]
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
RSUs
Restricted Stock Units (RSUs) [Member]
Statement of Income Location, Balance [Domain]
Statement of Income Location, Balance [Domain]
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
Entity Emerging Growth Company
Entity Emerging Growth Company
2027
Finance Lease, Liability, to be Paid, Year One
Shares issuable upon exercise of warrants pursuant to debt financing / Torii amendment
Warrants
Warrant [Member]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Weighted average remaining lease term (years)
Finance Lease, Weighted Average Remaining Lease Term
Outstanding beginning balance (in shares)
Outstanding ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]
Change in fair value of derivative liability
Change in fair value of derivative liability
Derivative, Gain (Loss) on Derivative, Net
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Operating
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Less imputed interest
Finance Lease, Liability, Undiscounted Excess Amount
Common stock, shares outstanding (in shares)
Common Stock, Shares, Outstanding
Loss on termination of financing lease
Gain (Loss) on Termination of Lease
PEO
PEO [Member]
Reportable Segment
Reportable Segment [Member]
Reportable Segment
Aggregate additional payments contingent on achievement of milestones
Revenue, Remaining Performance Obligation, Variable Consideration Amount
Revenue, Remaining Performance Obligation, Variable Consideration Amount
Interest income
Investment Income, Interest
Lytix
Lytix [Member]
Lytix.
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]
Accumulated Deficit
Retained Earnings [Member]
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Recognition of R&D funding liability
Research And Development Funding Liability Recognized
Research And Development Funding Liability Recognized
R&D funding liability (Note 10)
Research And Development Funding Liability, Noncurrent
Research And Development Funding Liability, Noncurrent
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Restatement Determination Date
Restatement Determination Date
Segment Reporting, Disaggregation Of Expenses [Axis]
Segment Reporting, Disaggregation Of Expenses [Axis]
Segment Reporting, Disaggregation Of Expenses
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Cash and restricted cash at the beginning of the period
Cash and restricted cash at the end of the period
Total Cash and Restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Income Statement [Abstract]
Income Statement [Abstract]
Interest rate margin percentage
Debt Instrument, Basis Spread on Variable Rate
Sale of Stock [Domain]
Sale of Stock [Domain]
Royalty payment period for subsequent products, option two
License Agreement, Maximum Royalty Payment Period, Subsequent Products, Option Two
License Agreement, Maximum Royalty Payment Period, Subsequent Products, Option Two
Preferred stock, shares issued (in shares)
Preferred Stock, Shares Issued
Pension Adjustments Service Cost
Pension Adjustments Service Cost [Member]
Achievement of Milestone [Domain]
Achievement of Milestone [Domain]
Achievement of Milestone [Domain].
Interest expense percentage
Imputed Interest Rate, Percentage
Imputed Interest Rate, Percentage
Product and Service [Domain]
Product and Service [Domain]
Customer Concentration Risk
Customer Concentration Risk [Member]
Commercial-related costs
Commercial related costs
Commercial related costs.
Interest expense
Interest Expense, Debt, Excluding Amortization
Options vested and exercisable, Weighted average exercise price (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Liabilities measured at fair value
Liabilities, Fair Value Disclosure
Debt Financing
Debt Financing [Member]
Debt financing.
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Landlord's Operating Expense
Landlord [Member]
Landlord.
Amortization of operating lease right-of-use asset
Operating Lease, Right-of-Use Asset, Periodic Reduction
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
City Area Code
City Area Code
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
License And Collaboration Agreements [Line Items]
License And Collaboration Agreements [Line Items]
License and collaboration agreements.
All Trading Arrangements
All Trading Arrangements [Member]
Equity Awards Adjustments, Footnote
Equity Awards Adjustments, Footnote [Text Block]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Cash flows from investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Unrecognized compensation for stock options
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Net cash used in operating activities
Cash outflows from operations
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Related Party Transactions [Abstract]
Related Party Transactions [Abstract]
Preferred stock, par value (in dollars per share)
Preferred Stock, Par or Stated Value Per Share
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Schedule of Lease Expense, Weighted Average Remaining Lease Term and Discount Rates
Lease, Cost [Table Text Block]
PEO Total Compensation Amount
PEO Total Compensation Amount
Depreciation expense
Depreciation
Equity Components [Axis]
Equity Components [Axis]
Number of reportable segments not disclosed
Number Of Reportable Segments Not Disclosed Flag
Number Of Reportable Segments Not Disclosed Flag
Organization and Description of Business Operations
Nature of Operations [Text Block]
License and Collaboration Agreements
License And Collaboration Agreements [Text Block]
License and collaboration agreements.
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Product revenue, net
Product revenue, net
Product [Member]
Expired (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Warrant term
Warrants and Rights Outstanding, Term
Supplemental disclosures
Supplemental Cash Flow Information [Abstract]
Other Performance Measure, Amount
Other Performance Measure, Amount
Weighted average exercise price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Repayment of finance lease
Finance Lease, Principal Payments
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Fair Value Measurement
Fair Value Measurement, Policy [Policy Text Block]
Loan Facility
Loan Facility [Member]
Loan facility.
Total current liabilities
Liabilities, Current
Vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Individual:
Individual [Axis]
Restricted cash
Restricted Cash
Leases
Lessee, Finance Leases [Text Block]
Royalty payment period for subsequent products, option one
License Agreement, Maximum Royalty Payment Period, Subsequent Products, Option One
License Agreement, Maximum Royalty Payment Period, Subsequent Products, Option One
Right-of-use asset and finance lease liability recognized
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Research and development
Research and Development Expense [Member]
Additional paid-in capital
Additional Paid in Capital, Common Stock
Net cash used in investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]
License and Collaboration Revenue, Commercial Supply and Development
License And Collaboration Revenue, Commercial Supply And Development [Member]
License And Collaboration Revenue, Commercial Supply And Development
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activity
Document Fiscal Year Focus
Document Fiscal Year Focus
Basis of Presentation / Unaudited Interim Financial Statements
Basis of Accounting, Policy [Policy Text Block]
Commercial (including payroll)
Commercial [Member]
Commercial [Member]
Operating lease right-of-use asset
Operating Lease, Right-of-Use Asset
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
Entity Interactive Data Current
Entity Interactive Data Current
Operating lease costs
Operating Lease, Cost
Torii Amendment, Tranche Three
Torii Amendment, Tranche Three [Member]
Torii Amendment, Tranche Three
Weighted-average recognition period for unrecognized compensation
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Equity [Abstract]
Equity [Abstract]
Financial Instruments - Derivatives
Derivatives, Policy [Policy Text Block]
Total finance lease costs
Finance Lease Cost
Finance lease, cost.
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Class of Warrant or Right [Table]
Class of Warrant or Right [Table]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
2028
Finance Lease, Liability, to be Paid, Year Two
Selling, general and administrative
Selling, General and Administrative Expense
Other non-current assets
Other Assets, Noncurrent
Customer [Domain]
Customer [Domain]
Entity Central Index Key
Entity Central Index Key
PEO Name
PEO Name
Fair Value of Financial Instruments and Credit Risk
Fair Value of Financial Instruments and Credit Risk [Policy Text Block]
Fair value of financial instruments and credit risk.
Total revenue
Revenue
Revenues
Net proceeds received upon issuance of stock
Sale of Stock, Consideration Received on Transaction
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]
Finished goods
Inventory, Finished Goods, Gross
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
License And Collaboration Agreements [Table]
License And Collaboration Agreements [Table]
License and collaboration agreements.
Accounts Receivable
Accounts Receivable [Policy Text Block]
Lease liability
Finance Lease, Liability
Arrangement Duration
Trading Arrangement Duration
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Deferred revenue
Contract with Customer, Liability, Current
Warrant exercise price (in dollars per share)
Exercise price (in dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Segments [Axis]
Segments [Axis]
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Exercise Price
Award Exercise Price
Entity Filer Category
Entity Filer Category
Local Phone Number
Local Phone Number
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Unrecognized compensation for non-option awards
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Total costs incurred
Collaborative Arrangement, Rights and Obligations, Costs Incurred, Total
Collaborative Arrangement, Rights and Obligations, Costs Incurred, Total
ASSETS
Assets [Abstract]
VP-315
VP-315 [Member]
VP-315 [Member]
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Pre Funded Warrants
Pre-funded warrants issued pursuant to the Private Placement
Pre Funded Warrant [Member]
Pre funded warrant.
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
Thereafter
Lessee Operating Lease Liability Payments Due After Year Three
Lessee, operating lease, liability payments due after year three.
Class of Warrant or Right [Domain]
Class of Warrant or Right [Domain]
Debt Instrument [Axis]
Debt Instrument [Axis]
Royalty payment period for first product
License Agreement, Maximum Royalty Payment Period, Initial Product
License Agreement, Maximum Royalty Payment Period, Initial Product
Loss on extinguishment of debt
Gain (Loss) on Extinguishment of Debt
Early repayment of senior debt
Early Repayment of Senior Debt
Stockholders’ equity:
Equity, Attributable to Parent [Abstract]
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Two
Research and development
Costs recognized in research and development expense
Research and Development Expense
Operating lease liability
Operating Lease, Liability, Noncurrent
Work in process
Inventory, Work in Process, Gross
Contra-research and development expense
Recovery Of Research And Development
Recovery Of Research And Development
Fair Value as of Grant Date
Award Grant Date Fair Value
Entity Registrant Name
Entity Registrant Name
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
Awards granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Collaboration receivable, billed and unbilled
Increase Decrease in License and Collaboration Receivable, Billed and Unbilled
Increase decrease in license and collaboration receivable, billed and unbilled.
Options vested and exercisable (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Document Quarterly Report
Document Quarterly Report
Issuance costs
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
Assets measured at fair value
Assets, Fair Value Disclosure
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Counterparty Name [Domain]
Counterparty Name [Domain]
2028
Lessee, Operating Lease, Liability, to be Paid, Year Two
Number of operating segments
Number of Operating Segments
Reverse stock split, conversion ratio
Stockholders' Equity Note, Stock Split, Conversion Ratio
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
Weighted average remaining contractual life (in years), Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Title
Trading Arrangement, Individual Title
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Contra-research and development expense since inception
Research And Development, Recovery to Date
Research And Development, Recovery to Date
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Restatement Determination Date:
Restatement Determination Date [Axis]
Non-PEO NEO
Non-PEO NEO [Member]
Aggregate intrinsic value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Accounts Receivable
Accounts Receivable [Member]
Interest expense including amortization of debt issuance costs
Interest Expense, Debt
R&D Funding Liability
Research And Development Funding Liability, Gross
Research And Development Funding Liability, Gross
Deferred R&D Services
Deferred Costs, Research And Development
Deferred Costs, Research And Development
Sale of Stock [Axis]
Sale of Stock [Axis]
Name
Trading Arrangement, Individual Name
Award Type [Domain]
All Award Types
Award Type [Domain]
Repayment of debt
Payment for Debt Extinguishment or Debt Prepayment Cost
2027
Lessee, Operating Lease, Liability, to be Paid, Year One
License and Collaboration Revenue, Milestones
License And Collaboration Revenue, Milestones [Member]
License And Collaboration Revenue, Milestones
Equity Awards Adjustments
Equity Awards Adjustments [Member]
Pension Benefits Adjustments, Footnote
Pension Benefits Adjustments, Footnote [Text Block]
Compensation Amount
Outstanding Recovery Compensation Amount
Basic exercise price (in dollars per share)
Basic Exercise Price
Basic Exercise Price
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Vesting percentage for shares underlying warrants
Class of Warrant Or Right, Securities Called By Warrants Or Rights, Vesting Percentage
Class of Warrant Or Right, Securities Called By Warrants Or Rights, Vesting Percentage
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Accounts receivable payment terms
Accounts Receivable, Current, Threshold Period Past Due
Accounts Receivable, Current, Threshold Period Past Due
Revenue:
Revenues [Abstract]
2026 (remaining 9 months)
Finance Lease, Liability, to be Paid, Remainder of Fiscal Year
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Treasury stock, at cost, 10,514 shares as of March 31, 2026 and December 31, 2025
Treasury Stock, Value
Finance lease cost:
Lessee, Finance Lease Cost [Abstract]
Lessee, Finance Lease Cost
Schedule of Maturities of Finance Leases
Finance Lease, Liability, to be Paid, Maturity [Table Text Block]
Operating lease:
Lessee, Operating Lease Cost [Abstract]
Lessee, Operating Lease Cost
Financial Instruments [Domain]
Financial Instruments [Domain]
Segments [Domain]
Segments [Domain]
Statement of Income Location, Balance [Axis]
Statement of Income Location, Balance [Axis]
Aggregate Pension Adjustments Service Cost
Aggregate Pension Adjustments Service Cost [Member]
Shares issuable upon exercise of Series A and B warrants pursuant to 2024 equity financing
Series A and B Warrants Pursuant to Two Thousand Twenty Four [Member]
Series a and b warrants pursuant to two thousand twenty four [Member]
Inventory
Increase (Decrease) in Inventories
Diluted exercise price (in dollars per share)
Diluted Exercise Price
Diluted Exercise Price
Inventory
Total inventory
Inventory, Net
Net Loss Per Share
Earnings Per Share, Policy [Policy Text Block]
Company Selected Measure Name
Company Selected Measure Name
Common warts
Common Warts [Member]
Common warts [Member]
Revenue
Revenue [Policy Text Block]
Cost of Product Revenue
Cost of Goods and Service [Policy Text Block]
Debt
Debt Disclosure [Text Block]
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Preferred Stock, Value, Issued
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Accounts payable
Accounts Payable, Current
Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
All Executive Categories
All Executive Categories [Member]
Common stock, $0.0001 par value; 200,000,000 authorized; 17,189,300 shares issued and 17,178,786 shares outstanding as of March 31, 2026 and December 31, 2025
Common Stock, Value, Issued
Finance lease right-of-use asset
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Weighted-average common shares outstanding, diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Segments
Segment Reporting, Policy [Policy Text Block]
Commitments and Contingencies (Note 5)
Commitments and Contingencies
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Cost of collaboration revenue
Cost of License And Collaboration Revenue [Member]
Cost of License And Collaboration Revenue
Cost of product revenue
Cost of product revenue
Cost Of Product Revenue
Cost Of Product Revenue
Deferred revenue recognition period
Contract With Customer, Liability, Recognition Period
Contract With Customer, Liability, Recognition Period
Entity Small Business
Entity Small Business
Offering expenses
Payments of Stock Issuance Costs
Preferred stock, shares outstanding (in shares)
Preferred Stock, Shares Outstanding
Document Transition Report
Document Transition Report
Total lease payments
Finance Lease, Liability, to be Paid
Underlying Securities
Award Underlying Securities Amount
Torii Amendment, Tranche Two
Torii Amendment, Tranche Two [Member]
Torii Amendment, Tranche Two
Equity Component [Domain]
Equity Component [Domain]
Operating
Operating Lease, Additional Information [Abstract]
Operating Lease, Additional Information
Document Period End Date
Document Period End Date
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Series C Warrants
Shares issuable upon exercise of Series C warrants pursuant to the Private Placement
Series C warrants issued pursuant to the Private Placement
Series C Warrants [Member]
Series C Warrants
Net proceeds received
Proceeds from Lines of Credit
Allowance for credit losses
Accounts Receivable, Allowance for Credit Loss
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
Operating lease liability
Increase (Decrease) in Operating Lease Liability
Deferred R&D services, non-current portion (Note 10)
Deferred Costs, Research And Development, Noncurrent
Deferred Costs, Research And Development, Noncurrent
Document Type
Document Type
Name
Outstanding Recovery, Individual Name
Product and Service [Axis]
Product and Service [Axis]
Total costs incurred since inception
Collaborative Arrangement, Rights and Obligations, Costs Incurred, Total Incurred to Date
Collaborative Arrangement, Rights and Obligations, Costs Incurred, Total Incurred to Date
Warrants issued in connection with OrbiMed debt facility
Orbi Med Debt Facility [Member]
Orbi med debt facility.
Revenue recognized
Revenue recognized
Revenue from Contract with Customer, Excluding Assessed Tax
All Individuals
All Individuals [Member]
Schedule of Accrued Expenses and Other Current Liabilities
Schedule of Accrued Expenses and Other Current Liabilities [Table Text Block]
Schedule of accrued expenses and other current liabilities.
Name
Forgone Recovery, Individual Name
Achievement of Milestone [Axis]
Achievement of Milestone [Axis]
Achievement of milestone.
Total current assets
Assets, Current
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]
Vehicles
Vehicles [Member]
Reconciliation of Cash and Restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Current liabilities:
Liabilities, Current [Abstract]
Additional Disclosures
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Lessee Lease Description [Line Items]
Lessee, Lease, Description [Line Items]
Total operating expenses
Operating Expenses
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
License agreement additional milestone payments
License Agreement Additional Milestone Payments
Additional milestone payments to be made under the license agreement.
Line of credit amount borrowed
Long-Term Line of Credit
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Related Party Transaction [Table]
Related Party Transaction [Table]
Net loss per share, diluted (in dollars shares)
Earnings Per Share, Diluted
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Accounts receivable
Accounts receivable
Accounts Receivable, after Allowance for Credit Loss, Current
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Title of 12(b) Security
Title of 12(b) Security
Lessee Lease Description [Table]
Lessee, Lease, Description [Table]
Aggregate intrinsic value, Options vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Supplemental disclosure of noncash investing and financing activities:
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
YCANTH (VP-102)
YCANTH [Member]
YCANTH.
Series B warrants issued pursuant to 2024 underwritten public offering
Series B warrants [Member]
Series B warrants.
Finance lease liability extinguished as a result of lease termination
Finance Lease Liability Extinguished as a Result of Lease Termination
Finance lease liability extinguished as a result of lease termination.
Cost of License and Collaboration Revenue
Cost Of License And Collaboration Revenue [Policy Text Block]
Cost of license and collaboration revenue.
Treasury stock (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Treasury Stock, Common, Shares
Total other income (expense), net
Other income (expense)
Nonoperating Income (Expense)
Pass Through Costs
Pass Through Costs [Member]
Pass Through Costs
Schedule of Potential Shares Outstanding not Included in Computation of Diluted Net Loss Per Common Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Accrued Expenses and Other Current Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Pre Funded Warrant and Series C Warrants
Pre Funded Warrant And Series C Warrants [Member]
Pre Funded Warrant And Series C Warrants
Award Timing Disclosures [Line Items]
Schedule of Inventory
Schedule of Inventory, Current [Table Text Block]
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Compensation and related costs
Employee-related Liabilities, Current
Total lease payments
Lessee, Operating Lease, Liability, to be Paid
Number of shares exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
Payment of equity issuance costs
Equity Issuance Costs
Equity Issuance Costs
Stockholders’ Equity
Equity [Text Block]
Collaboration receivable, billed and unbilled
License and Collaboration Receivable, Billed and Unbilled
License and collaboration receivable, billed and unbilled.
Inventory
Accrued Inventory, Current
Accrued Inventory, Current
Net loss
Net loss
Net loss
Net Income (Loss) Attributable to Parent
Expiration Date
Trading Arrangement Expiration Date
Operating lease, base rent
Operating Lease Base Rent Expense
Operating lease, base rent expense.
Related party, amounts of transaction
Related Party Transaction, Amounts of Transaction
Change in deferred R&D services
Change In Deferred Costs, Research And Development
Change In Deferred Costs, Research And Development
Property and equipment, net
Property, Plant and Equipment, Net
Non-cash interest expense
Non Cash Interest Expense
Non cash interest expense.
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Preferred stock, shares authorized (in shares)
Preferred Stock, Shares Authorized
Adoption Date
Trading Arrangement Adoption Date
Weighted average remaining contractual life (in years), Options vested and exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Inventory
Inventory, Policy [Policy Text Block]
Clinical trials and drug development
Accrued Clinical Trial And Drug Development Current
Accrued clinical trial and drug development current.
Entity Current Reporting Status
Entity Current Reporting Status
Segment Reporting, Disaggregation Of Expenses [Domain]
Segment Reporting, Disaggregation Of Expenses [Domain]
Segment Reporting, Disaggregation Of Expenses [Domain]
Customer [Axis]
Customer [Axis]
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Loss from operations
Operating Income (Loss)
Accumulated deficit
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Finance
Finance Lease, Additional Information [Abstract]
Finance Lease, Additional Information
Financial Instrument [Axis]
Financial Instrument [Axis]
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]
Executive Category:
Executive Category [Axis]
Other unallocated expenses
Other Unallocated Expenses [Member]
Other unallocated expenses [Member]
Finance lease liability
Finance Lease, Liability, Current
Current Fiscal Year End Date
Current Fiscal Year End Date
Common Stock and Series C Warrants
Common Stock And Series C Warrants [Member]
Common Stock And Series C Warrants
Thereafter
Finance Lease Liability Payments Due After Year Three
Finance lease liability payments due after year three.
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]
Payables and Accruals [Abstract]
Payables and Accruals [Abstract]
Other expense
Other Nonoperating Income (Expense)
Statement [Table]
Statement [Table]
Derivative liability
Derivative Liability
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Cash flows from financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Weighted average grant date fair value per share (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Equity Awards Adjustments, Excluding Value Reported in Compensation Table
Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]
Finance lease liability
Finance Lease, Liability, Noncurrent
Fixed interest rate percentage
Debt Instrument, Fixed Interest Rate, Percentage
Debt Instrument, Fixed Interest Rate, Percentage
Securities that could potentially dilute basic earnings per share (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Amendment Flag
Amendment Flag
Purchase price of stock (in dollars per share)
Sale of Stock, Price Per Share
Ltyix
Lytix Biopharma A S [Member]
Lytix Biopharma AS.
Leases
Lessee, Operating Leases [Text Block]
Termination Date
Trading Arrangement Termination Date
Bank cash deposits
Interest-Bearing Deposits in Banks and Other Financial Institutions
Net cash used in financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
Measure:
Measure [Axis]
Cash
Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]
Costs paid by the other party
Collaborative Arrangement, Rights and Obligations, Amount Paid By Other Party
Collaborative Arrangement, Rights and Obligations, Amount Paid By Other Party
Weighted average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Schedule of Outstanding Warrants
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies [Text Block]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Weighted-average common shares outstanding, basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
License agreement milestone payment amount paid
License Agreement Milestone Payment Amount Paid
Milestone payment made under the license agreement.
Description Of Business [Line Items]
Description Of Business [Line Items]
Description Of Business [Line Items]
Related Party Transaction [Domain]
Related Party Transaction [Domain]
Deferred R&D services, current portion (Note 10)
Deferred Costs, Research And Development, Current
Deferred Costs, Research And Development, Current
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Debt Disclosure [Abstract]
Debt Disclosure [Abstract]
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Development Regulatory Commercial Milestones
Development Regulatory Commercial Milestones [Member]
DevelopmentRegulatoryCommercial Milestones.
Entity Tax Identification Number
Entity Tax Identification Number
Cost of product revenue
Cost Of Product Revenue [Member]
Cost Of Product Revenue
Outstanding beginning balance (in dollars per share)
Outstanding ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Common stock, shares issued (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Issued
Weighted average remaining lease term (years)
Operating Lease, Weighted Average Remaining Lease Term
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Number of votes per common share
Common Stock, Voting Rights, Number Of Votes
Common Stock, Voting Rights, Number Of Votes
Interest expense
Interest expense
Interest Expense, Nonoperating
Trading Arrangement:
Trading Arrangement [Axis]
Total Shareholder Return Amount
Total Shareholder Return Amount
Description Of Business [Table]
Description Of Business [Table]
Description Of Business [Table]
Insider Trading Arrangements [Line Items]
Security Exchange Name
Security Exchange Name
Forfeited (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Raw materials
Inventory, Raw Materials, Gross
Total liabilities
Liabilities
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Pension Adjustments Prior Service Cost
Pension Adjustments Prior Service Cost [Member]
Operating expenses:
Operating Expenses [Abstract]
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
Other current liabilities
Other Liabilities, Current
Statement [Line Items]
Statement [Line Items]
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Cash
Cash and cash equivalents
Cash and Cash Equivalent
Counterparty Name [Axis]
Counterparty Name [Axis]
Common Stock
Common Stock [Member]
Awards vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Non-NEOs
Non-NEOs [Member]
Finance
Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Net decrease in cash and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Professional fees
Accrued Professional Fees, Current